Androgen Deprivation Therapy Market 2022 Global Trends, Market Share, Industry Size, Growth, Opportunities and Forecast to 2030

Androgen deprivation therapy is also coupled with external beam radiotherapy to treat intermediate and high-risk prostate cancer. The global androgen deprivation therapy market is poised to grow lucratively with the rising cases of prostate cancers, also the advancing healthcare and research to fuel the market growth further.

Coronavirus pandemic has also shaped the global androgen deprivation therapy market. It has been found in a study that patients of prostate cancer who received the androgen deprivation therapy were at lower risk of coronavirus. Therefore, these findings indicate that the androgen deprivation therapy market has propelled in the coronavirus crisis.

Request for a sample here @ https://www.persistencemarketresearch.com/samples/31996

Androgen Deprivation Therapy Market: Drivers and Restraints

The growth of the global androgen deprivation therapy market is driven by the rising cases and deaths by prostate cancer, innovative technologies, advancing healthcare expenditure and facilities, increasing global awareness and demand for better treatment. The R&D bodies are actively dwelling to develop novel androgen deprivation therapy for cancer. The approval of new drugs have also propelled the androgen deprivation therapy market growth.

However, the market growth is constrained by the resistance developed during the treatments, side effects such as hot flashes, erectile dysfunction, low bone density, insulin resistance etc. Androgen deprivation therapy is ineffective for hormone-refractory prostate cancer. The high expenses and poor reimbursement of treatment expenses hinder the market growth. Although, the overall global androgen deprivation therapy market is anticipated to grow further due to the increasing cases of prostate cancer, improving R&D and healthcare facilities.

Ask for Table Of Content here @ https://www.persistencemarketresearch.com/toc/31996

Androgen Deprivation Therapy Market: Segmentation

By drug class
  • Luteinizing Hormone-Releasing Hormone (LHRH) agonists
  • LHRH antagonists
  • Antiandrogens
  • Others
By route of administration
  • Injectable
  • Oral
By end-users
  • Hospitals
  • Clinics
  • Others

Androgen Deprivation Therapy Market: Regional Outlook

North America leads the global androgen deprivation therapy market with the high prevalence of prostate cancer, massive R&D investments, advanced healthcare expenditure and development novel immunotherapies. Europe holds the second largest global androgen deprivation therapy market with its advanced healthcare facilities and massive research investments.

Asia-Pacific androgen deprivation therapy market is the fastest emerging and is driven by the increasing burden of prostate cancer, increasing awareness, and government aids, improving healthcare facilities and advancing research. Latin America androgen deprivation therapy market is growing with the increasing prevalence of prostate cancer, progressing research and healthcare facilities. The Middle East & Africa androgen deprivation therapy market is least lucrative due to the lack of awareness and underdeveloped healthcare infrastructure.

Androgen Deprivation Therapy Market: Key Players

The key players of the global androgen deprivation therapy market include Allergan plc, Amgen, Bayer, AstraZeneca, Johnson & Johnson, Pfizer, Sanofi and others.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

Get up to 20% off on Immediate Purchase @ https://www.persistencemarketresearch.com/checkout/31996

About Us:

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

Contact Us:

Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – [email protected]
Website – https://www.persistencemarketresearch.com

Leave a Comment

%d bloggers like this: